-transparent.png){kind=logo}
The effects of several doses of intracerebroventricularly injected cholecystokinin octapeptide sulfate ester (CCK-8-SE) and nonsulfated scholecystokinin octapeptide (CCK-8-NS) were studied on electroconvulsive shock (ECS)-induced retrograde amnesia, as measured in a one-trial step-through passive avoidance paradigm. Both CCK-8-SE and CCK-8-NS were able to attenuate amnesia slightly when they were injected into rats 10 min prior to ECS treatment, possibly by reducing the severity of the ECS-induced seizures. Of the treatments carried out immediately after ECS, only the 0.8 pmole dose of CCK-8-NS could significantly restore retrograde amnesia. After treatment 20 min prior to testing 24-hr retention, no effect of the peptides was observed. The lack of a dose-dependency and of any effect on retrieval raises the possibility that the CCK octapeptides influence memory processes by an indirect mechanism.
T Kádár, and
B Penke, and
K Kovács, and
G Telegdy
January 1983,
Peptides,
T Kádár, and
B Penke, and
K Kovács, and
G Telegdy
January 1997,
Peptides,
T Kádár, and
B Penke, and
K Kovács, and
G Telegdy
March 1970,
Physiology & behavior,
T Kádár, and
B Penke, and
K Kovács, and
G Telegdy
December 1978,
Behavioral biology,
T Kádár, and
B Penke, and
K Kovács, and
G Telegdy
March 2012,
Journal of neural transmission (Vienna, Austria : 1996),
T Kádár, and
B Penke, and
K Kovács, and
G Telegdy
August 1978,
Pharmacology, biochemistry, and behavior,
T Kádár, and
B Penke, and
K Kovács, and
G Telegdy
February 1964,
Science (New York, N.Y.),
T Kádár, and
B Penke, and
K Kovács, and
G Telegdy
December 1983,
Die Pharmazie,
T Kádár, and
B Penke, and
K Kovács, and
G Telegdy
March 1965,
Archives internationales de pharmacodynamie et de therapie,
T Kádár, and
B Penke, and
K Kovács, and
G Telegdy
April 1982,
Behavioral and neural biology,
